Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease

International Journal of Clinical Practice

Volumn 65, Issue 9, 2011, Pages 939-944

  Weiss, T W ^a,b,c   Seljeflot, I ^a,c   Hjerkinn, E M ^a   Arnesen, H ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b Wilhelminenhospital   (Austria)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERLEUKIN 18; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADIPOSE TISSUE; ADIPOSE TISSUE PROINFLAMMATORY ACTIVITY SCORE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SCORING SYSTEM; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; HUMANS; INTERLEUKIN-18; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 9; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUNICA MEDIA;

EID: 80051863017     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2011.02717.x     Document Type: Article

References (21)

1. Sehested TS, Hansen TW, Olsen MH, et al., Measures of overweight and obesity and risk of cardiovascular disease: a population-based study. Eur J Cardiovasc Prev Rehabil 2010; 17: 486-90.
2. Hajer GR, van Haeften TW, Visseren FL,. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29: 2959-71.
3. Prescott MF, Sawyer WK, Von Linden-Reed J, et al., Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury. Ann N Y Acad Sci 1999; 878: 179-90. (Pubitemid 29353569)
4. Vaughan DE,. PAI-1 and atherothrombosis. J Thromb Haemost 2005; 3: 1879-83. (Pubitemid 41716575)
5. Blankenberg S, Rupprecht HJ, Poirier O, et al., Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 2003; 107: 1579-85. (Pubitemid 36397324)
6. Macfelda K, Weiss TW, Kaun C, et al., Plasminogen activator inhibitor 1 expression is regulated by the inflammatory mediators interleukin-1alpha, tumor necrosis factor-alpha, transforming growth factor-beta and oncostatin M in human cardiac myocytes. J Mol Cell Cardiol 2002; 34: 1681-91. (Pubitemid 35454482)
7. Rega G, Kaun C, Weiss TW, et al., Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue. Circulation 2005; 111: 1938-45. (Pubitemid 40570213)
8. Gadient RA, Patterson PH,. Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem Cells 1999; 17: 127-37. (Pubitemid 29226663)
9. Berg AH, Scherer PE,. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939-49. (Pubitemid 40712793)
10. Packard RR, Libby P,. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008; 54: 24-38. (Pubitemid 351182593)
11. Weiss TW, Furenes EB, Troseid M, et al., Prediction of cardiovascular events by matrix metalloproteinase (MMP)-9 in elderly men. Thromb Haemost 2010; 103: 679-81.
12. Lijnen HR,. Plasmin and matrix metalloproteinases in vascular remodeling. Thromb Haemost 2001; 86: 324-33. (Pubitemid 32663963)
13. Hjermann I, Velve Byre K, Holme I, Leren P,. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet 1981; 2: 1303-10. (Pubitemid 12180386)
14. Hjerkinn EM, Abdelnoor M, Breivik L, et al., Effect of diet or very long chain omega-3 fatty acids on progression of atherosclerosis, evaluated by carotid plaques, intima-media thickness and by pulse wave propagation in elderly men with hypercholesterolaemia. Eur J Cardiovasc Prev Rehabil 2006; 13: 325-33. (Pubitemid 44318641)
15. Busetto L, Bassetto F, Zocchi M, et al., The effects of the surgical removal of subcutaneous adipose tissue on energy expenditure and adipocytokine concentrations in obese women. Nutr Metab Cardiovasc Dis 2008; 18: 112-20. (Pubitemid 351282468)
16. Esposito K, Giugliano G, Scuderi N, Giugliano D,. Role of adipokines in the obesity-inflammation relationship: the effect of fat removal. Plast Reconstr Surg 2006; 118: 1048-57. discussion 58-9. (Pubitemid 44412941)
17. Giugliano G, Nicoletti G, Grella E, et al., Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg 2004; 57: 190-4. (Pubitemid 38380434)
18. Konstantino Y, Nguyen TT, Wolk R, et al., Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease. Biomarkers 2009; 14: 118-29.
19. Hidalgo M, Eckhardt SG,. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 2001; 93: 178-93. (Pubitemid 32166488)
20. Hidalgo M, Eckhardt SG,. Matrix metalloproteinase inhibitors: how can we optimize their development? Ann Oncol 2001; 12: 285-7. (Pubitemid 32288682)
21. Malemud CJ,. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 2006; 11: 1696-701. (Pubitemid 43253387)